FPRX - ファイブ・プライム・セラピュ―ティクス （Five Prime Therapeutics Inc.）

Five Prime Therapeutics Inc. shares closed this week 69.9% higher than it did at the end of last week. The stock is currently up 122.0% year-to-date, up 912.3% over the past 12 months, and up 6.9% over the past five years. This week, the Dow Jones Industrial Average rose 1.9%, and the S&P 500 rose 0.9%. Trading Activity Shares traded as high as $38.18 and as low as $21.13 this week.Trading volume this week was 15.3% higher than the 10-day average and 247.4% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 803.7% The company's stock price performance over the past 12 months beats the peer average by 2530.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Five Prime Therapeutics Inc. shares closed today at 1.1% below its 52 week high of $38.18, giving the company a market cap of $1B. The stock is currently up 123.4% year-to-date, up 889.6% over the past 12 months, and up 10.0% over the past five years. This week, the Dow Jones Industrial Average fell 1.4%, and the S&P 500 fell 1.5%. Trading Activity Trading volume this week was 995.7% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 940.9% The company's stock price performance over the past 12 months beats the peer average by 3222.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Five Prime Therapeutics Inc. shares closed today 11.1% higher than it did at the end of yesterday. The stock is currently up 40.0% year-to-date, up 344.4% over the past 12 months, and down 29.1% over the past five years. Today, the Dow Jones Industrial Average fell 0.0%, and the S&P 500 fell 0.2%. Trading Activity Shares traded as high as $23.87 and as low as $19.03 this week.Shares closed 4% below its 52-week high and 1e+3% above its 52-week low.Trading volume this week was 13.5% higher than the 10-day average and 32.4% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index today, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 112.8% The company's stock price performance over the past 12 months beats the peer average by 868.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Five Prime Therapeutics Inc. shares closed this week 22.1% higher than it did at the end of last week. The stock is currently up 40.0% year-to-date, up 344.4% over the past 12 months, and down 29.1% over the past five years. This week, the Dow Jones Industrial Average rose 0.2%, and the S&P 500 fell 0.7%. Trading Activity Shares traded as high as $23.87 and as low as $19.03 this week.Shares closed 4% below its 52-week high and 1e+3% above its 52-week low.Trading volume this week was 13.5% higher than the 10-day average and 32.4% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 112.8% The company's stock price performance over the past 12 months beats the peer average by 868.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Five Prime Therapeutics Inc. shares closed today 11.1% higher than it did at the end of yesterday. The stock is currently up 26.0% year-to-date, up 385.1% over the past 12 months, and down 32.5% over the past five years. Today, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 fell 0.2%. Trading Activity Shares traded as high as $23.87 and as low as $19.03 this week.Shares closed 4% below its 52-week high and 1e+3% above its 52-week low.Trading volume this week was 70.8% higher than the 10-day average and 0.5% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index today, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 39.0% The company's stock price performance over the past 12 months beats the peer average by 1067.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Five Prime Therapeutics Inc. shares closed this week 69.9% higher than it did at the end of last week. The stock is currently up 122.0% year-to-date, up 912.3% over the past 12 months, and up 6.9% over the past five years. This week, the Dow Jones Industrial Average rose 1.9%, and the S&P 500 rose 0.9%. Trading Activity Shares traded as high as $38.18 and as low as $21.13 this week.Trading volume this week was 15.3% higher than the 10-day average and 247.4% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 803.7% The company's stock price performance over the past 12 months beats the peer average by 2530.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Five Prime Therapeutics Inc. shares closed today at 1.1% below its 52 week high of $38.18, giving the company a market cap of $1B. The stock is currently up 123.4% year-to-date, up 889.6% over the past 12 months, and up 10.0% over the past five years. This week, the Dow Jones Industrial Average fell 1.4%, and the S&P 500 fell 1.5%. Trading Activity Trading volume this week was 995.7% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 940.9% The company's stock price performance over the past 12 months beats the peer average by 3222.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Five Prime Therapeutics Inc. shares closed today 11.1% higher than it did at the end of yesterday. The stock is currently up 40.0% year-to-date, up 344.4% over the past 12 months, and down 29.1% over the past five years. Today, the Dow Jones Industrial Average fell 0.0%, and the S&P 500 fell 0.2%. Trading Activity Shares traded as high as $23.87 and as low as $19.03 this week.Shares closed 4% below its 52-week high and 1e+3% above its 52-week low.Trading volume this week was 13.5% higher than the 10-day average and 32.4% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index today, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 112.8% The company's stock price performance over the past 12 months beats the peer average by 868.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Five Prime Therapeutics Inc. shares closed this week 22.1% higher than it did at the end of last week. The stock is currently up 40.0% year-to-date, up 344.4% over the past 12 months, and down 29.1% over the past five years. This week, the Dow Jones Industrial Average rose 0.2%, and the S&P 500 fell 0.7%. Trading Activity Shares traded as high as $23.87 and as low as $19.03 this week.Shares closed 4% below its 52-week high and 1e+3% above its 52-week low.Trading volume this week was 13.5% higher than the 10-day average and 32.4% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 112.8% The company's stock price performance over the past 12 months beats the peer average by 868.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Five Prime Therapeutics Inc. shares closed today 11.1% higher than it did at the end of yesterday. The stock is currently up 26.0% year-to-date, up 385.1% over the past 12 months, and down 32.5% over the past five years. Today, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 fell 0.2%. Trading Activity Shares traded as high as $23.87 and as low as $19.03 this week.Shares closed 4% below its 52-week high and 1e+3% above its 52-week low.Trading volume this week was 70.8% higher than the 10-day average and 0.5% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index today, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 39.0% The company's stock price performance over the past 12 months beats the peer average by 1067.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.